{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:03:59Z","timestamp":1795025039998,"version":"4.10.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The geographical distribution of hepatitis B virus (HBV) and hepatitis D virus (HDV) genotypes is uneven and has its own clinical and organizational implications for health systems. Despite the introduction of vaccination and successful antiviral therapy the prevalence of chronic hepatitis B (with or without delta agent) increased over the past 5 years. This study aimed for the first time to investigate the molecular epidemiology of HBV and HDV in Kazakhstan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Total 834 chronic hepatitis B (with or without delta agent) patients were included to the study from November 2017 to June 2019. The material was collected from the regional hepatological \u0441enters from 13 cities of Kazakhstan. Genotyping of HBV\/HDV isolates was carried out using phylogenetic analysis of null-binary sequences of Kazakhstani isolates, in comparison with the reference sequences. Nucleotide sequence alignment was performed using the ClustalW algorithm, the \u201cneighbor-joining\u201d method was used for the construction of phylogenetic trees and subsequent analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall 341 samples were PCR-positive and genotyped for HBV. Comparison and phylogenetic analysis of nucleotide sequences of HBV isolates showed that they were represented by genotypes HBV-D (95.9%), HBV-A (3.5%) and HBV-C (0.6%). At the same time, the identity of the nucleotide sequences of Kazakhstani isolates were: HBV-D (95\u2013100%); HBV-A (97.2\u2013100%) and HBV-C (99%). 256 samples were PCR positive and genotyped for HDV, all of them belonged to genotype 1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study describes for the first time the molecular epidemiology of HBV and HDV in Kazakhstan. The data obtained expand the knowledge of the global epidemiology of viruses; have potential implications for public health policy and for further clinical research on chronic hepatitis in Kazakhstan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT05095181 (registered on 27\/10\/2021).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08524-1","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T14:02:18Z","timestamp":1692021738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and genotypes distribution of virus hepatitis B and hepatitis delta virus in chronic liver diseases in Kazakhstan"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4468-593X","authenticated-orcid":false,"given":"Bibigul S.","family":"Ilyassova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-8151","authenticated-orcid":false,"given":"Balzhan","family":"Abzhaparova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-7104","authenticated-orcid":false,"given":"Dariga S.","family":"Smailova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5390-4623","authenticated-orcid":false,"given":"Aidos","family":"Bolatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-6853","authenticated-orcid":false,"given":"Bolatbek","family":"Baymakhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-156X","authenticated-orcid":false,"given":"Vyacheslav","family":"Beloussov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-1055","authenticated-orcid":false,"given":"Maxim","family":"Solomadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-3850","authenticated-orcid":false,"given":"Kunsulu","family":"Shamsivaliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-279X","authenticated-orcid":false,"given":"Gulnara","family":"Alpysbayava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-6825","authenticated-orcid":false,"given":"Gaukhar","family":"Issakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-5543","authenticated-orcid":false,"given":"Joanna","family":"Granica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-3378","authenticated-orcid":false,"given":"Dina","family":"Mukushkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-1513","authenticated-orcid":false,"given":"Inkar Y.","family":"Sagatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-8931","authenticated-orcid":false,"given":"Shokan","family":"Kaniyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"8524_CR1","unstructured":"World Health Organization. (2016). Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. https:\/\/apps.who.int\/iris\/handle\/10665\/246177."},{"issue":"12","key":"8524_CR2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/gut.18.12.997","volume":"18","author":"M Rizzetto","year":"1977","unstructured":"Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (\u03b4\/anti-\u03b4) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997\u20131003. https:\/\/doi.org\/10.1136\/gut.18.12.997.","journal-title":"Gut"},{"issue":"2","key":"8524_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5501\/wjv.v4.i2.36","volume":"4","author":"E Shirvani-Dastgerdi","year":"2015","unstructured":"Shirvani-Dastgerdi E. Molecular interactions between hepatitis B virus and delta virus. World J Virol. 2015;4(2):36. https:\/\/doi.org\/10.5501\/wjv.v4.i2.36.","journal-title":"World J Virol"},{"key":"8524_CR4","doi-asserted-by":"publisher","unstructured":"Sakupova GA, Glushkova NYe, Smagul SZhN, Smagulova MA, Kasabekova MK, Khismetova EK. Z.A. Analysis of the long-term dynamics of the incidence of viral hepatitis B and C in the territory of the Republic of Kazakhstan (retrospective analysis) \/\/ Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 4, pp. 163\u201371. Doi https:\/\/doi.org\/10.34689\/SH.2021.23.4.018.","DOI":"10.34689\/SH.2021.23.4.018"},{"key":"8524_CR5","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/IDR.S363609","volume":"15","author":"A Ashimkhanova","year":"2022","unstructured":"Ashimkhanova A, Syssoyev D, Gusmanov A, Yesmembetov K, Yespotayeva A, Abbay A, Nurpeissova A, Sarria-Santamera A, Gaipov A. Epidemiological characteristics of chronic viral Hepatitis in Kazakhstan: data from Unified Nationwide Electronic Healthcare System 2014\u20132019. Infect drug Resist. 2022;15:3333\u201346. https:\/\/doi.org\/10.2147\/IDR.S363609.","journal-title":"Infect drug Resist"},{"key":"8524_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S363609","author":"A Ashimkhanova","year":"2022","unstructured":"Ashimkhanova A, Syssoyev D, Gusmanov A, Yesmembetov K, Yespotayeva A, Abbay A, \u2026, Gaipov A. Infect Drug Resist. 2022;15:3333\u201346. https:\/\/doi.org\/10.2147\/IDR.S363609. Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014\u20132019."},{"key":"8524_CR7","doi-asserted-by":"publisher","unstructured":"Jumabayeva, A., Nersesov, A., Kulzhanov, M., Nefedova, M., Nuraliyeva, G., Rakhimbekova, G., ? Fakhradiyev, I. (2022). Prevalence of Viral Hepatitis B, C, and D in Kazakhstan. Scientific World Journal, 2022. https:\/\/doi.org\/10.1155\/2022\/9102565.","DOI":"10.1155\/2022\/9102565"},{"issue":"3","key":"8524_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1055\/s-0032-1323628","volume":"32","author":"P Farci","year":"2012","unstructured":"Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. 2012;32(3):228\u201336. https:\/\/doi.org\/10.1055\/s-0032-1323628.","journal-title":"Semin Liver Dis"},{"key":"8524_CR9","doi-asserted-by":"publisher","unstructured":"Taylor JM. (2009). Chapter 3 replication of the Hepatitis Delta Virus RNA genome. Advances in Virus Research. https:\/\/doi.org\/10.1016\/S0065-3527(09)74003-5.","DOI":"10.1016\/S0065-3527(09)74003-5"},{"issue":"3","key":"8524_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jhep.2015.04.025","volume":"63","author":"T Kushner","year":"2015","unstructured":"Kushner T, Serper M, Kaplan DE. Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes. J Hepatol. 2015;63(3):586\u201392. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.025.","journal-title":"J Hepatol"},{"issue":"10","key":"8524_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/jnci\/djs168","volume":"104","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma. J Natl Cancer Inst. 2012;104(10):790\u20132. https:\/\/doi.org\/10.1093\/jnci\/djs168.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"8524_CR12","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/JCM.42.6.2455-2460.2004","volume":"42","author":"R Sitnik","year":"2004","unstructured":"Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Silva D, L. C., Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in brazilian patients. J Clin Microbiol. 2004;42(6):2455\u201360. https:\/\/doi.org\/10.1128\/JCM.42.6.2455-2460.2004.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8524_CR13","first-page":"174","volume":"4","author":"L Shahinsaz","year":"2006","unstructured":"Shahinsaz L, Sabahi F, Karimi M, Behzadian F, Alavian SM, Zand V. Detection and genotyping of Hepatitis D Virus from HBsAg positive patients in Iran using RT-PCR. Iran J Biotechnol. 2006;4(3):174\u20139.","journal-title":"Iran J Biotechnol"},{"key":"8524_CR14","unstructured":"Genotyping tool - help. (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/projects\/genotyping\/help.html."},{"issue":"4","key":"8524_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/oxfordjournals.molbev.a040454","volume":"4","author":"N Saitou","year":"1987","unstructured":"Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406\u201325. https:\/\/doi.org\/10.1093\/oxfordjournals.molbev.a040454.","journal-title":"Mol Biol Evol"},{"issue":"30","key":"8524_CR16","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1073\/pnas.0404206101","volume":"101","author":"K Tamura","year":"2004","unstructured":"Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA. 2004;101(30):11030\u20135. https:\/\/doi.org\/10.1073\/pnas.0404206101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"8524_CR17","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.3748\/wjg.v20.i18.5427","volume":"20","author":"M Sunbul","year":"2014","unstructured":"Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014;20(18):5427\u201334. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5427.","journal-title":"World J Gastroenterol"},{"key":"8524_CR18","doi-asserted-by":"publisher","unstructured":"Lin CL, Kao JH. (2011). The clinical implications of hepatitis B virus genotype: recent advances. Journal of Gastroenterology and Hepatology (Australia). Blackwell Publishing. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06541.x.","DOI":"10.1111\/j.1440-1746.2010.06541.x"},{"issue":"1","key":"8524_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11894-011-0233-5","volume":"14","author":"S Tanwar","year":"2012","unstructured":"Tanwar S, Dusheiko G. Is there any value to hepatitis B virus genotype analysis? Curr Gastroenterol Rep. 2012;14(1):37\u201346. https:\/\/doi.org\/10.1007\/s11894-011-0233-5.","journal-title":"Curr Gastroenterol Rep"},{"issue":"50","key":"8524_CR20","doi-asserted-by":"publisher","first-page":"e27941","DOI":"10.1097\/MD.0000000000027941","volume":"100","author":"Z Liu","year":"2021","unstructured":"Liu Z, Zhang Y, Xu M, Li X, Zhang Z. Distribution of hepatitis B virus genotypes and subgenotypes: a meta-analysis. Medicine. 2021;100(50):e27941. https:\/\/doi.org\/10.1097\/MD.0000000000027941.","journal-title":"Medicine"},{"key":"8524_CR21","doi-asserted-by":"publisher","unstructured":"Liu CJ, Kao JH. (2013). Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes a to J. Seminars in Liver Disease. https:\/\/doi.org\/10.1055\/s-0033-1345716.","DOI":"10.1055\/s-0033-1345716"},{"issue":"10","key":"8524_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/genes9100495","volume":"9","author":"S Velkov","year":"2018","unstructured":"Velkov S, Ott JJ, Protzer U, Michler T. The Global Hepatitis B Virus genotype distribution approximated from available genotyping data. Genes. 2018;9(10):495. https:\/\/doi.org\/10.3390\/genes9100495.","journal-title":"Genes"},{"issue":"3","key":"8524_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C, Hutin Y, Geretti AM. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020;73(3):523\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.008.","journal-title":"J Hepatol"},{"issue":"6","key":"8524_CR24","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/hep.29574","volume":"66","author":"F Le Gal","year":"2017","unstructured":"Le Gal F, Brichler S, Drugan T, Alloui C, Roulot D, Pawlotsky JM, D\u00e9ny P, Gordien E. Genetic diversity and worldwide distribution of the deltavirus genus: a study of 2,152 clinical strains. Hepatology (Baltimore MD). 2017;66(6):1826\u201341. https:\/\/doi.org\/10.1002\/hep.29574.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"24","key":"8524_CR25","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.3748\/wjg.v27.i24.3530","volume":"27","author":"GA Niro","year":"2021","unstructured":"Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: from infection to new therapeutic strategies. World J Gastroenterol. 2021;27(24):3530\u201342. https:\/\/doi.org\/10.3748\/wjg.v27.i24.3530.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08524-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T14:03:53Z","timestamp":1700229833000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08524-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8524"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08524-1","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is being carried out in accordance with relevant guidelines and regulations. All participants had given written informed consent to one of the study investigators in accordance with the Declaration of Helsinki. Study was approved by the institutional review board of Local Ethical Committee of the National Scientific Center of Surgery named after A.N.Syzganov (Almaty, Kazakhstan) on 14 September 2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ClinicalTrials.gov NCT05095181 (registered on 27\/10\/2021).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"533"}}